BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31169214)

  • 21. Effects of full-neck volumetric-modulated arc therapy vs split-field intensity-modulated head and neck radiation therapy on low neck targets and structures.
    Anamalayil SJ; Teo BK; Lin A; Lustig RA; Ahn PH
    Br J Radiol; 2016 Jun; 89(1062):20160009. PubMed ID: 27043353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance of the Brachial Plexus to High-Dose Reirradiation.
    Chen AM; Yoshizaki T; Velez MA; Mikaeilian AG; Hsu S; Cao M
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):83-90. PubMed ID: 28587056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
    Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
    Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
    [No Abstract]   [Full Text] [Related]  

  • 24. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.
    Mohindra P; Urban E; Pagan JD; Geye HM; Patel VB; Bayliss RA; Bender ET; Harari PM
    Head Neck; 2016 Apr; 38(4):499-505. PubMed ID: 25445257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptive Radiotherapy for Head and Neck Cancer.
    Surucu M; Shah KK; Roeske JC; Choi M; Small W; Emami B
    Technol Cancer Res Treat; 2017 Apr; 16(2):218-223. PubMed ID: 27502958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
    Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
    J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.
    Eblan MJ; Corradetti MN; Lukens JN; Xanthopoulos E; Mitra N; Christodouleas JP; Grover S; Fernandes AT; Langer CJ; Evans TL; Stevenson J; Rengan R; Apisarnthanarax S
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):175-81. PubMed ID: 22658442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
    Forquer JA; Fakiris AJ; Timmerman RD; Lo SS; Perkins SM; McGarry RC; Johnstone PA
    Radiother Oncol; 2009 Dec; 93(3):408-13. PubMed ID: 19454366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
    Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
    Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy.
    Wu SG; Huang SJ; Zhou J; Sun JY; Guo H; Li FY; Lin Q; Lin HX; He ZY
    Radiat Oncol; 2014 Dec; 9():292. PubMed ID: 25499205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosimetric analysis of the brachial plexus using Monte Carlo-based intensity-modulated radiotherapy for head and neck cancer.
    Lee JJ; Lei M; Connor S; Siddiqui A; Lynn R; Convery D; Guerrero Urbano T
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):516-7. PubMed ID: 24954283
    [No Abstract]   [Full Text] [Related]  

  • 35. Compensator-based intensity-modulated radiotherapy in head and neck cancer: our experience in achieving dosimetric parameters and their clinical correlation.
    Nangia S; Chufal KS; Arivazhagan V; Srinivas P; Tyagi A; Ghosh D
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):485-92. PubMed ID: 16909973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy.
    Yi SK; Mak W; Yang CC; Liu T; Cui J; Chen AM; Purdy JA; Monjazeb AM; Do L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):376-82. PubMed ID: 22342301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results.
    Shen Q; Ma X; Hu W; Chen L; Huang J; Guo Y
    Radiat Oncol; 2013 Jun; 8():152. PubMed ID: 23800149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
    Leung WS; Wu VWC; Liu CYW; Cheng ACK
    J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.